Local media cover $13.5 million gift benefiting ALS research and patient care
Donation from Hugh H. Hoffman estate supports UC Gardner Neuroscience Institute
A historic $13.5 million gift from the estate of Hugh H. Hoffman will revolutionize amyotrophic lateral sclerosis (ALS) at the ALS Multidisciplinary Clinic at the University of Cincinnati Gardner Neuroscience Institute.
Hoffman's nephew, Bert Bullock, and Rob Neel, MD, announced the gift on Sunday, April 28, at an event for ALS patients and families at the Cincinnati Zoo & Botanical Garden.
Neel, MD, a specialist in ALS and autoimmune neuromuscular disorders and director of the ALS Multidisciplinary Clinic, said the donation is "meteoric" and "climate-changing" for ALS patients and families in Greater Cincinnati and beyond.
Read media coverage about the gift, the second largest in the UC Gardner Neuroscience Institute's history.
Read the Cincinnati Business Courier story.
Read the Movers & Makers story.
Featured image at top: Dr. Robert Neel shares details about the Hugh H. Hoffman estate gift. Hoffman's image is in the background. Photo/UC Health
Next, Now
With its focus on innovation and impact, Next, Now: The Campaign for Cincinnati is where ambition meets action. At the University of Cincinnati and UC Health, we’re driven by next; thinking bolder and dreaming bigger to create the tomorrow we envision, today. Learn more at nextnow.uc.edu.
Related Stories
UC biologist talks about 'pearmageddon'
March 16, 2026
WLWT talks to UC biologist and Department Head Theresa Culley about invasive, nonnative Callery pear trees that are spreading across Ohio forests after they were introduced by landscapers more than 50 years ago.
Local media highlight completion of Blood Cancer Healing Center fourth and fifth floors
March 16, 2026
Local media including WLWT and the Cincinnati Business Courier highlighted the opening of research laboratories and the UC Osher Wellness Suite and Learning Kitchen at the University of Cincinnati Cancer Center’s Blood Cancer Healing Center.
Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy
March 16, 2026
Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.